TernaryTx, a pioneering biotech startup, with a revolutionary AI-driven platform for designing molecular glue therapeutics, opening new frontiers in drug discovery for previously "undruggable" targets.
Ternary Therapeutics has raised €4.2M across 1 funding round from 4 investors, most recently a Seed round in Mar 2026. Based in London, UK; active in AI. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-18 | Seed | €4.2M |
| Future Planet Capital,i&i Biotech Fund,Pace Ventures,The UK Innovation & Science Seed Fund |
| View deal → |
